✦ LIBER ✦

Clinical significance of TP53 mutation in myeloma

✍ Scribed by Chng, W J; Price-Troska, T; Gonzalez-Paz, N; Van Wier, S; Jacobus, S; Blood, E; Henderson, K; Oken, M; Van Ness, B; Greipp, P

Book ID: 110057040
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 111 KB
Volume: 21
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404524

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TP53 in hematological cancer: Low incide

TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance

✍ Shoshana Peller; Varda Rotter 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

Inactivation of the wild-type p53 gene (TP53) by various genetic alterations is a major event in human tumorigenesis. More than 60% of human primary tumors exhibit a mutation in the p53 gene. Hematological malignancies present a rather low incidence of genetic alterations in this gene (10-20%). Neve

TP53 mutation in colorectal cancer

✍ Barry Iacopetta 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Approximately half of all colorectal cancers show p53 (TP53) gene mutations, with higher frequencies observed in distal colon and rectal tumors and lower frequencies in proximal tumors and those with the microsatellite instability or methylator phenotypes. Alterations to this gene appear to have lit

Clinical and biological significance of

Clinical and biological significance of RAS mutations in multiple myeloma

✍ Chng, W J; Gonzalez-Paz, N; Price-Troska, T; Jacobus, S; Rajkumar, S V; Oken, M 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB

TP53 mutations in clinically normal muco

TP53 mutations in clinically normal mucosa adjacent to oral carcinomas

✍ C. Thode; A. Bilde; C. Von Buchwald; E. Dabelsteen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

Significance of TP53 mutations in human

Significance of TP53 mutations in human cancer: A critical analysis of mutations at CpG dinucleotides

✍ Thierry Soussi; Christophe Béroud 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

A detailed analysis of p53 (TP53) mutations involving the 42 CpG dinucleotides was performed to gain greater insight into the mutational mechanism leading to specific selection of these mutations. Although the majority of these CpG dinucleotides have been found to be mutated in cancer cells, the het

TP53 mutations in human skin cancers

✍ Giuseppina Giglia-Mari; Alain Sarasin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

The p53 gene (TP53) is mutated in numerous human cancers. We have used it as a molecular target to characterize the induction of mutations in human skin cancers. About 50% of all skin cancers in normal individuals exhibit p53 mutations. This frequency rises to 90% in skin cancers of patients with th